Skip to main content
Leila Haghani, MD, Other MD/DO, Boston, MA

LeilaHaghaniMD

Other MD/DO Boston, MA

Vascular and Interventional Radiology/Oncology

Dr. Haghani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Haghani's full profile

Already have an account?

  • Office

    Boston
    Boston, MA 02114

Summary

  • Dr. Leila Haghani is based in Boston, MA, and specializes as an MD/DO. She completed her medical education at Tehran University of Medical Sciences in 2020 and a fellowship at Memorial Sloan Kettering Cancer Center from 2022 to 2023. Dr. Haghani is currently a Postdoc Researcher at UMass Memorial Medical Center. Her research includes significant publications in drug delivery systems and spinal cord injury, with over 700 citations for her 2016 review on smart micro/nanoparticles. She has been recognized with the Global Embolization award from GEST in 2024.

Education & Training

  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolBiomedical Research, Vascular and Interventional Radiology, 2024 - 2025
  • Tehran University of Medical Sciences School of Medicine
    Tehran University of Medical Sciences School of MedicineClass of 2021

Awards, Honors, & Recognition

  • IO Essentials Scholarship Society of Interventional Oncology’s (SIO), 2025
  • Global Embolization GEST, 2024
  • Recognized for research excellence through an invitation to Sigma Xi Scientific Research Honor Society, 2024
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Combination of Transarterial Radioembolization and Immunotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Leila Haghani, JVIR, Las Vegas
  • Systematic Review and Meta-Analysis Of Comparing the Efficacy of TACE Plus Lenvatinib with and without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
    Leila Haghani, JVIR, Nashville

Lectures

  • Factors Associated with Improved Overall Survival for Patients Undergoing Embolization of Metastatic Melanoma 
    Arizona

Authored Content

  • Unlocking the Potential of Targeted Cancer Therapy for Precision MedicineAugust 2024

Press Mentions

  • Leila Haghani: Feeling inspired to push the boundaries of medical innovation
    Leila Haghani: Feeling inspired to push the boundaries of medical innovationAugust 8th, 2024

Grant Support

  • Smart micro/ nanoparticles in Stimulus-Responsive Drug/Gene Delivery SystemsNIHPresent

Committees

  • Postdoc Fellow, Society of Interventional Radiology 2022 - 2024
  • SIO line SIRRFS, Society of Interventional Radiology (SIR), Awarded 320 points,
  • Editorial board trainee, Radiology Society of North America (RSNA)
  • Editorial Board Trainee, JVIR Journal

Professional Memberships

  • Society of interventional radiology (SIR)
    Fellow
  • Society of Interventional Oncology
    Fellow

Other Languages

  • Turkish, Dari, Urdu, Farsi, Tajik